Patents by Inventor Bum-Joon Park

Bum-Joon Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12156902
    Abstract: The present invention relates to a method of treating bone, joint, muscle, and connective tissue related inflammatory disease comprising administering to a subject in need thereof a composition comprising an isolated peptide of SEQ ID NO: 1.
    Type: Grant
    Filed: August 9, 2023
    Date of Patent: December 3, 2024
    Assignee: GemVax & KAEL Co., Ltd.
    Inventors: Sang Jae Kim, Kyung Hee Kim, Kyu-Yong Lee, Seong-Ho Koh, Hyun-Hee Park, Sung Jin Huh, Woo Jin Lee, Bum Joon Kim
  • Publication number: 20240092741
    Abstract: The present invention relates to a composition for prevention or treatment of neurofibromatosis type 2 syndrome, wherein in contrast to the conventional T?R1 kinase inhibitor TEW7197, the compound represented by chemical formula 1, a pharmaceutically acceptable salt thereof, a solvate thereof, a stereoisomer thereof, or a combination thereof according to the present invention suppresses TGF-? receptor 1 (T?R1)-mediated RKIP reduction while not inhibiting normal TGF-? signaling and thus, can be used as a novel form of a therapeutic agent for neurofibromatosis type 2 syndrome, which can solve the side effect problem caused by the inhibition of normal TGF-? signaling.
    Type: Application
    Filed: January 24, 2022
    Publication date: March 21, 2024
    Applicant: PRG S&TECH INC.
    Inventors: Bum-Joon PARK, Hwayoung YUN
  • Publication number: 20220402930
    Abstract: The present invention relates to a use of a novel compound, for preventing, improving or treating amyotrophic lateral sclerosis (ALS). The present inventors have found that SOD1 aggregation is one of the important causes of ALS, and have proposed the possibility that WT-SOD1 aggregation, caused by suppressing the regulation of intracellular stress or TDP-43, may be a cause of sALS. In addition, the present inventors have discovered the novel compound PRG-A-01(SLC-B036) as a SOD1 aggregation and misfolding inhibitor. The compound exhibited a protective effect against muscle weakness and movement disorder in an ALS mouse model. According to the result of a histological analysis, intraspinal nerves were maintained by means of a treatment using PRG-A-01(SLC-B036). In addition, the present inventors have obtained a candidate compound (PRG-A-04) which can be a more optimized drug. Consequently, the compound of the present invention may be usefully employed in developing a therapeutic agent for ALS.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 22, 2022
    Applicant: PRG S&TECH INC.
    Inventor: Bum-Joon PARK
  • Patent number: 11008332
    Abstract: A composition for preventing or treating an aging-related disease includes a novel decursin derivative as an active ingredient, wherein the novel decursin derivative has exhibited an excellent effect of inhibiting progerin expression and excellent effect of inhibiting binding between progerin and lamin A, and it has been confirmed that the novel decursin derivative prolongs the survival period of animal models in which progerin was induced.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: May 18, 2021
    Assignee: PRG S&TECH INC
    Inventors: Bum Joon Park, Gyu Yong Song, Yu Seok O, Jee Hyun Lee, Eun Ju Yun
  • Patent number: 10943728
    Abstract: The coil spacer structure according to an embodiment of the present disclosure includes a body block, a low tension coil support member coupled to the body block, and a high tension coil support member coupled to the body block. A plurality of protrusions are formed on an outer peripheral portion of the body block, and a first groove is formed between the protrusions.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: March 9, 2021
    Assignee: LSIS CO., LTD.
    Inventor: Bum-Joon Park
  • Publication number: 20200048274
    Abstract: A composition for preventing or treating an aging-related disease includes a novel decursin derivative as an active ingredient, wherein the novel decursin derivative has exhibited an excellent effect of inhibiting progerin expression and excellent effect of inhibiting binding between progerin and lamin A, and it has been confirmed that the novel decursin derivative prolongs the survival period of animal models in which progerin was induced.
    Type: Application
    Filed: April 25, 2018
    Publication date: February 13, 2020
    Applicant: PRG S&TECH INC.
    Inventors: Bum Joon PARK, Gyu Yong SONG, Yu Seok O, Jee Hyun LEE, Eun Ju YUN
  • Patent number: 10280178
    Abstract: Disclosed is a new compound that inhibits binding between a DX2 protein and a p14/ARF protein, a pharmaceutical composition including the new compound as an effective component for treating or preventing a cancer disease, an anticancer adjuvant for improving an anticancer effect of a drug-resistant anticancer drug, and a composition including an AIMP2-DX2 protein or a fragment thereof for diagnosing lung cancer.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: May 7, 2019
    Assignees: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC)
    Inventors: Bum Joon Park, Gyu Yong Song, Ah-Young Oh, Jee-Hyun Lee, Jin-Hyuk Her
  • Publication number: 20180362540
    Abstract: Disclosed is a new compound that inhibits binding between a DX2 protein and a p14/ARF protein, a pharmaceutical composition including the new compound as an effective component for treating or preventing a cancer disease, an anticancer adjuvant for improving an anticancer effect of a drug-resistant anticancer drug, and a composition including an AIMP2-DX2 protein or a fragment thereof for diagnosing lung cancer.
    Type: Application
    Filed: August 10, 2018
    Publication date: December 20, 2018
    Applicants: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOP ERATION FOUNDATION, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NA TIONAL UNIVERSITY (IAC)
    Inventors: Bum Joon PARK, Gyu Yong SONG, Ah-Young OH, Jee-Hyun LEE, Jin-Hyuk HER
  • Publication number: 20180286571
    Abstract: The coil spacer structure according to an embodiment of the present disclosure includes a body block, a low tension coil support member coupled to the body block, and a high tension coil support member coupled to the body block. A plurality of protrusions are formed on an outer peripheral portion of the body block, and a first groove is formed between the protrusions.
    Type: Application
    Filed: March 27, 2018
    Publication date: October 4, 2018
    Inventor: Bum-Joon PARK
  • Patent number: 10072021
    Abstract: Disclosed is a new compound that inhibits binding between a DX2 protein and a p14/ARF protein, a pharmaceutical composition including the new compound as an effective component for treating or preventing a cancer disease, an anticancer adjuvant for improving an anticancer effect of a drug-resistant anticancer drug, and a composition including an AIMP2-DX2 protein or a fragment thereof for diagnosing lung cancer.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: September 11, 2018
    Assignees: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC)
    Inventors: Bum Joon Park, Gyu Yong Song, Ah-Young Oh, Jee-Hyun Lee, Jin-Hyuk Her
  • Publication number: 20170129904
    Abstract: Disclosed is a new compound that inhibits binding between a DX2 protein and a p14/ARF protein, a pharmaceutical composition including the new compound as an effective component for treating or preventing a cancer disease, an anticancer adjuvant for improving an anticancer effect of a drug-resistant anticancer drug, and a composition including an AIMP2-DX2 protein or a fragment thereof for diagnosing lung cancer.
    Type: Application
    Filed: June 30, 2015
    Publication date: May 11, 2017
    Applicants: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC)
    Inventors: Bum Joon PARK, Gyu Yong SONG, Ah-Young OH, Jee-Hyun LEE, Jin-Hyuk HER
  • Patent number: 9508541
    Abstract: Provided is a substrate treatment apparatus. The substrate treatment apparatus includes a load port on which a carrier accommodating a plurality of substrates to which a back-ground wafer is attached to a mounting tape fixed to a frame ring is placed, a plasma treatment unit supplying plasma to treat a top surface of the wafer, and a substrate transfer unit transferring the substrate between the carrier and the plasma treatment unit.
    Type: Grant
    Filed: January 2, 2014
    Date of Patent: November 29, 2016
    Assignee: PSK INC.
    Inventors: Jongjin Lee, Bum Joon Park, Tae Hoon Kim, Chang Weon Lee, Sunwoong Yim, Han Kyu Lee
  • Patent number: 9400281
    Abstract: Provided are compounds for inhibiting Snail-p53 binding and therapeutic agents for cancer including the compounds as an effective component. The Snail-p53 binding inhibitors induce expression of p53 in K-Ras mutant cell lines, thereby enabling effective treatment or prevention of K-Ras mutant cancer, such as, pancreatic cancer, lung cancer, cholangioma, and colon cancer, of which diagnosis or treatment is not easy.
    Type: Grant
    Filed: December 31, 2013
    Date of Patent: July 26, 2016
    Assignees: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY
    Inventors: Bum Joon Park, Nam Chul Ha, Sun Hye Lee, Gyu Yong Song, Jee Hyun Lee
  • Patent number: 9249153
    Abstract: Disclosed are a method for treating an aging-related disease and a method for screening a therapeutic agent for an aging-related disease. The method for treating an aging-related disease includes administering to a subject a progerin expression inhibitor as an active ingredient. The method for screening a therapeutic agent for an aging-related disease includes selecting a candidate drug inhibitory of progerin expression.
    Type: Grant
    Filed: March 19, 2012
    Date of Patent: February 2, 2016
    Assignees: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY
    Inventors: Bum Joon Park, Nam Chul Ha, Gyu Yong Song, Ji Hyun Lee, Su Jin Lee, Youn Sang Jung
  • Publication number: 20150186426
    Abstract: The disclosure is related to a method of providing a search service by a service server using a plurality of wearable computing devices registered at the service server for the search service. The method may include selecting wearable computing devices located within a predetermined distance from a target search location among the registered wearable computing devices, requesting the selected wearable computing devices to collect information on a target search object through a communication network, receiving the requested information from the selected wearable computing devices through the communication network, and providing the received information to user equipment that requests searching information on the target search location and the target search object.
    Type: Application
    Filed: December 30, 2014
    Publication date: July 2, 2015
    Inventors: Yeong-Hwan JEONG, Bum-Joon PARK, Hyun-Sook KIM, Ji-Wan SONG
  • Publication number: 20140190513
    Abstract: Provided is a substrate treatment apparatus. The substrate treatment apparatus includes a load port on which a carrier accommodating a plurality of substrates to which a back-ground wafer is attached to a mounting tape fixed to a frame ring is placed, a plasma treatment unit supplying plasma to treat a top surface of the wafer, and a substrate transfer unit transferring the substrate between the carrier and the plasma treatment unit.
    Type: Application
    Filed: January 2, 2014
    Publication date: July 10, 2014
    Inventors: Jongjin Lee, Bum Joon Park, Tae Hoon Kim, Chang Weon Lee, Sunwoong Yim, Han Kyu Lee
  • Publication number: 20140147866
    Abstract: Provided are compounds for inhibiting Snail-p53 binding and therapeutic agents for cancer including the compounds as an effective component. The Snail-p53 binding inhibitors induce expression of p53 in K-Ras mutant cell lines, thereby enabling effective treatment or prevention of K-Ras mutant cancer, such as, pancreatic cancer, lung cancer, cholangioma, and colon cancer, of which diagnosis or treatment is not easy.
    Type: Application
    Filed: December 31, 2013
    Publication date: May 29, 2014
    Applicants: THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY, PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
    Inventors: Bum Joon PARK, Nam Chul Ha, Sun Hye Lee, Gyu Yong Song, Jee Hyun Lee
  • Publication number: 20140039010
    Abstract: Disclosed are a method for treating an aging-related disease and a method for screening a therapeutic agent for an aging-related disease. The method for treating an aging-related disease includes administering to a subject a progerin expression inhibitor as an active ingredient. The method for screening a therapeutic agent for an aging-related disease includes selecting a candidate drug inhibitory of progerin expression.
    Type: Application
    Filed: March 19, 2012
    Publication date: February 6, 2014
    Applicant: Pusan National University Industry-University Cooperation Foundation
    Inventors: Bum Joon Park, Nam Chul Ha, Gyu Yong Song, Ji Hyun Lee, Su Jin Lee, Youn Sang Jung
  • Publication number: 20120015960
    Abstract: Provided are compounds for inhibiting Snail-p53 binding and therapeutic agents for cancer including the compounds as an effective component. The Snail-p53 binding inhibitors induce expression of p53 in K-Ras mutant cell lines, thereby enabling effective treatment or prevention of K-Ras mutant cancer, such as, pancreatic cancer, lung cancer, cholangioma, and colon cancer, of which diagnosis or treatment is not easy.
    Type: Application
    Filed: November 23, 2009
    Publication date: January 19, 2012
    Applicants: The Industry & Academic Cooperation in Chungnam National University, Pusan National University Industry-University Cooperation Foundation
    Inventors: Bum Joon Park, Nam Chul Ha, Sun Hye Lee, Gyu Yong Song, Jee Hyun Lee
  • Patent number: 7196068
    Abstract: The present invention relates to a method for treating cancer using p38/JTV-1 and a method for screening pharmaceutical composition for treating cancer. More particularly, this invention relates to the method for treating cancer, which comprises administering the effective amount of p38/JTV-1 protein or a nucleic acid encoding for said protein to the patient and the method for screening a pharmaceutical composition for treating cancer characterized by selecting a substance having an effect on the increase of the activity of the p38/JTV-1 protein and the intracellular level thereof.
    Type: Grant
    Filed: June 18, 2003
    Date of Patent: March 27, 2007
    Assignee: Seoul National University Industry Foundation
    Inventors: Sunghoon Kim, Bum-Joon Park